Keyhole limpet haemocyanin - A model antigen for human immunotoxicological studies

Ashwin Swaminathan*, Robyn M. Lucas, Keith Dear, Anthony J. McMichael

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    74 Citations (Scopus)

    Abstract

    Immunization with a T-cell dependent antigen has been promoted as a reliable and sensitive tool for assessing the influence of putative immunotoxic exposures or agents on immune function. Keyhole limpet haemocyanin (KLH) is a very large, copper-containing protein molecule derived from the haemolymph of the inedible mollusc, Megathura crenulata. KLH is a highly immunogenic T-cell dependent antigen that is used increasingly in immunotoxicological studies, particularly in those involving animals. This report systematically reviews the human clinical studies that have used trans-cutaneous KLH immunization for assessment of the influence of various physiological and disease states and exposures on immune function over the last 20 years (1994-2013). These studies varied in their immunization protocols, formulation of KLH, dose, site and route of administration and immunoassay platforms developed to assess KLH-specific responses. KLH immunization has been well tolerated with only mild to moderate adverse effects reported. Though very promising as a model antigen candidate in immunotoxicology research, more work on standardizing immunization and immunoassay protocols is required.

    Original languageEnglish
    Pages (from-to)1135-1142
    Number of pages8
    JournalBritish Journal of Clinical Pharmacology
    Volume78
    Issue number5
    DOIs
    Publication statusPublished - Nov 2014

    Fingerprint

    Dive into the research topics of 'Keyhole limpet haemocyanin - A model antigen for human immunotoxicological studies'. Together they form a unique fingerprint.

    Cite this